507 related articles for article (PubMed ID: 27521538)
1. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies.
Hu J; Zeng S; Zhou Q; Zhu W; Xu Z; Yu J; Hong K
Int J Cardiol; 2016 Nov; 222():689-695. PubMed ID: 27521538
[TBL] [Abstract][Full Text] [Related]
2. Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.
Romero J; Cerrud-Rodriguez RC; Di Biase L; Diaz JC; Alviz I; Grupposo V; Cerna L; Avendano R; Tedrow U; Natale A; Tung R; Kumar S
JACC Clin Electrophysiol; 2019 Jan; 5(1):13-24. PubMed ID: 30678778
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
[TBL] [Abstract][Full Text] [Related]
4. Should all patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergo epicardial catheter ablation?
Müssigbrodt A; Efimova E; Knopp H; Bertagnolli L; Dagres N; Richter S; Husser D; Bollmann A; Hindricks G; Arya A
J Interv Card Electrophysiol; 2017 Mar; 48(2):193-199. PubMed ID: 27900527
[TBL] [Abstract][Full Text] [Related]
5. Endocardial ablation to eliminate epicardial arrhythmia substrate in scar-related ventricular tachycardia.
Komatsu Y; Daly M; Sacher F; Cochet H; Denis A; Derval N; Jesel L; Zellerhoff S; Lim HS; Jadidi A; Nault I; Shah A; Roten L; Pascale P; Scherr D; Aurillac-Lavignolle V; Hocini M; Haïssaguerre M; Jaïs P
J Am Coll Cardiol; 2014 Apr; 63(14):1416-26. PubMed ID: 24486269
[TBL] [Abstract][Full Text] [Related]
6. Endo-epicardial vs endocardial-only catheter ablation of ventricular tachycardia: A meta-analysis.
Cardoso R; Assis FR; D'Avila A
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1537-1548. PubMed ID: 31172632
[TBL] [Abstract][Full Text] [Related]
7. Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
Romero J; Patel K; Briceno D; Alviz I; Gabr M; Diaz JC; Trivedi C; Mohanty S; Della Rocca D; Al-Ahmad A; Yang R; Rios S; Cerna L; Du X; Tarantino N; Zhang XD; Lakkireddy D; Natale A; Di Biase L
J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2022-2031. PubMed ID: 32478430
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome After Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Dilated Cardiomyopathy.
Muser D; Santangeli P; Castro SA; Pathak RK; Liang JJ; Hayashi T; Magnani S; Garcia FC; Hutchinson MD; Supple GG; Frankel DS; Riley MP; Lin D; Schaller RD; Dixit S; Zado ES; Callans DJ; Marchlinski FE
Circ Arrhythm Electrophysiol; 2016 Oct; 9(10):. PubMed ID: 27733494
[TBL] [Abstract][Full Text] [Related]
9. Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.
Tung R; Michowitz Y; Yu R; Mathuria N; Vaseghi M; Buch E; Bradfield J; Fujimura O; Gima J; Discepolo W; Mandapati R; Shivkumar K
Heart Rhythm; 2013 Apr; 10(4):490-8. PubMed ID: 23246598
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study.
Pisani CF; Romero J; Lara S; Hardy C; Chokr M; Sacilotto L; Wu TC; Darrieux F; Hachul D; Kalil-Filho R; Di Biase L; Scanavacca M
Heart Rhythm; 2020 Sep; 17(9):1510-1518. PubMed ID: 32087356
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation.
Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P
Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837
[TBL] [Abstract][Full Text] [Related]
12. Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial.
Hendriks AA; Khan M; Geller L; Kardos A; de Vries LJ; Yap SC; Wijchers SA; Theuns DA; Szili-Torok T
Trials; 2015 Oct; 16():487. PubMed ID: 26514959
[TBL] [Abstract][Full Text] [Related]
13. Catheter ablation of ventricular tachycardia and mortality in patients with nonischemic dilated cardiomyopathy: can noninducibility after ablation be a predictor for reduced mortality?
Dinov B; Arya A; Schratter A; Schirripa V; Fiedler L; Sommer P; Bollmann A; Rolf S; Piorkowski C; Hindricks G
Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):598-605. PubMed ID: 25873719
[TBL] [Abstract][Full Text] [Related]
14. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H
Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy: Late Potential Abolition and VT Noninducibility.
Okubo K; Gigli L; Trevisi N; Foppoli L; Radinovic A; Bisceglia C; Frontera A; D'Angelo G; Cireddu M; Paglino G; Mazzone P; Della Bella P
Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008307. PubMed ID: 32657137
[TBL] [Abstract][Full Text] [Related]
16. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach.
Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F
J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830
[TBL] [Abstract][Full Text] [Related]
17. Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.
Kanagaratnam A; Virk SA; Pham T; Anderson RD; Turnbull S; Campbell T; Bennett R; Thomas SP; Lee G; Kumar S
Heart Lung Circ; 2022 Aug; 31(8):1064-1074. PubMed ID: 35643798
[TBL] [Abstract][Full Text] [Related]
18. Epicardial only mapping and ablation of ventricular tachycardia: a case series.
Berte B; Yamashita S; Sacher F; Cochet H; Hooks D; Aljefairi N; Amraoui S; Denis A; Derval N; Hocini M; Haïssaguerre M; Jaïs P
Europace; 2016 Feb; 18(2):267-73. PubMed ID: 25840285
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
[TBL] [Abstract][Full Text] [Related]
20. Outcome of ventricular tachycardia ablation in patients with nonischemic cardiomyopathy: the impact of noninducibility.
Piers SR; Leong DP; van Huls van Taxis CF; Tayyebi M; Trines SA; Pijnappels DA; Delgado V; Schalij MJ; Zeppenfeld K
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):513-21. PubMed ID: 23619893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
